Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006265
Status:
COMPLETED
Last Update Posted:
2016-07-14
First Post:
2000-09-11
Brief Title:
Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-03
Start Date Type:
None
Primary Completion Date:
2004-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-05
Completion Date Type:
ACTUAL
First Submit Date:
2000-09-11
First Submit QC Date:
September 2 2003
Study First Post Date:
2003-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-12
Last Update Post Date:
2016-07-14
Last Update Post Date Type:
ESTIMATED